CN107418938B - 10-去乙酰巴卡亭III 10β-O-乙酰转移酶突变体及其在催化合成紫杉醇及其类似物中的应用 - Google Patents
10-去乙酰巴卡亭III 10β-O-乙酰转移酶突变体及其在催化合成紫杉醇及其类似物中的应用 Download PDFInfo
- Publication number
- CN107418938B CN107418938B CN201610346558.4A CN201610346558A CN107418938B CN 107418938 B CN107418938 B CN 107418938B CN 201610346558 A CN201610346558 A CN 201610346558A CN 107418938 B CN107418938 B CN 107418938B
- Authority
- CN
- China
- Prior art keywords
- dbat
- protein
- paclitaxel
- deacetyl
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- YWLXLRUDGLRYDR-ZHPRIASZSA-N 5beta,20-epoxy-1,7beta,10beta,13alpha-tetrahydroxy-9-oxotax-11-ene-2alpha,4alpha-diyl 4-acetate 2-benzoate Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](O)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 YWLXLRUDGLRYDR-ZHPRIASZSA-N 0.000 title claims abstract description 75
- 229930012538 Paclitaxel Natural products 0.000 title claims abstract description 43
- 229960001592 paclitaxel Drugs 0.000 title claims abstract description 43
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 title claims abstract description 42
- 238000007036 catalytic synthesis reaction Methods 0.000 title description 3
- TYLVGQKNNUHXIP-MHHARFCSSA-N 10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)C=4C=CC=CC=4)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 TYLVGQKNNUHXIP-MHHARFCSSA-N 0.000 claims abstract description 82
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 claims abstract description 49
- 102000008300 Mutant Proteins Human genes 0.000 claims abstract description 38
- 108010021466 Mutant Proteins Proteins 0.000 claims abstract description 38
- 125000002252 acyl group Chemical group 0.000 claims abstract description 24
- 239000000758 substrate Substances 0.000 claims abstract description 21
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 17
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 14
- 125000003147 glycosyl group Chemical group 0.000 claims abstract description 13
- 229940100228 acetyl coenzyme a Drugs 0.000 claims abstract description 12
- 239000002773 nucleotide Substances 0.000 claims abstract description 11
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 11
- 229940123237 Taxane Drugs 0.000 claims abstract description 8
- 108090000623 proteins and genes Proteins 0.000 claims description 36
- 102000004169 proteins and genes Human genes 0.000 claims description 31
- 102000004190 Enzymes Human genes 0.000 claims description 27
- 108090000790 Enzymes Proteins 0.000 claims description 27
- 238000006243 chemical reaction Methods 0.000 claims description 23
- 239000013612 plasmid Substances 0.000 claims description 15
- 230000035772 mutation Effects 0.000 claims description 13
- 102000004157 Hydrolases Human genes 0.000 claims description 12
- 108090000604 Hydrolases Proteins 0.000 claims description 12
- 238000005859 coupling reaction Methods 0.000 claims description 8
- 230000008878 coupling Effects 0.000 claims description 7
- 238000010168 coupling process Methods 0.000 claims description 7
- 150000001413 amino acids Chemical class 0.000 claims description 6
- 230000002255 enzymatic effect Effects 0.000 claims description 6
- 102200130585 rs778210210 Human genes 0.000 claims description 4
- 240000000599 Lentinula edodes Species 0.000 claims description 3
- 101000885693 Taxus cuspidata 10-deacetylbaccatin III 10-O-acetyltransferase Proteins 0.000 claims description 3
- 230000010933 acylation Effects 0.000 claims description 2
- 238000005917 acylation reaction Methods 0.000 claims description 2
- CRFNGMNYKDXRTN-CITAKDKDSA-N butyryl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCC)O[C@H]1N1C2=NC=NC(N)=C2N=C1 CRFNGMNYKDXRTN-CITAKDKDSA-N 0.000 claims description 2
- 102000037865 fusion proteins Human genes 0.000 claims description 2
- 108020001507 fusion proteins Proteins 0.000 claims description 2
- QAQREVBBADEHPA-IEXPHMLFSA-N propionyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC)O[C@H]1N1C2=NC=NC(N)=C2N=C1 QAQREVBBADEHPA-IEXPHMLFSA-N 0.000 claims description 2
- GKNWJYPYFJMILD-UHFFFAOYSA-N 1-[4-(2h-triazolo[4,5-c]pyridin-4-ylperoxy)-2h-triazolo[4,5-c]pyridin-6-yl]decan-1-one Chemical compound N=1C(C(=O)CCCCCCCCC)=CC=2NN=NC=2C=1OOC1=NC=CC2=C1N=NN2 GKNWJYPYFJMILD-UHFFFAOYSA-N 0.000 claims 1
- 230000003301 hydrolyzing effect Effects 0.000 claims 1
- 229930182986 10-Deacetyltaxol Natural products 0.000 abstract description 38
- -1 10-deacetyl taxane Chemical group 0.000 abstract description 5
- 230000015572 biosynthetic process Effects 0.000 abstract description 4
- 238000003786 synthesis reaction Methods 0.000 abstract description 3
- 235000018102 proteins Nutrition 0.000 description 25
- 230000003197 catalytic effect Effects 0.000 description 23
- OVMSOCFBDVBLFW-VHLOTGQHSA-N 5beta,20-epoxy-1,7beta,13alpha-trihydroxy-9-oxotax-11-ene-2alpha,4alpha,10beta-triyl 4,10-diacetate 2-benzoate Chemical compound O([C@@H]1[C@@]2(C[C@H](O)C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)O)C(=O)C1=CC=CC=C1 OVMSOCFBDVBLFW-VHLOTGQHSA-N 0.000 description 22
- 230000000694 effects Effects 0.000 description 15
- 239000000047 product Substances 0.000 description 15
- 238000006640 acetylation reaction Methods 0.000 description 13
- 239000006225 natural substrate Substances 0.000 description 13
- 244000162450 Taxus cuspidata Species 0.000 description 12
- 235000009065 Taxus cuspidata Nutrition 0.000 description 12
- 229930014667 baccatin III Natural products 0.000 description 11
- 230000021736 acetylation Effects 0.000 description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 9
- 241000588724 Escherichia coli Species 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 9
- 108091028043 Nucleic acid sequence Proteins 0.000 description 8
- 239000000370 acceptor Substances 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 8
- 239000000872 buffer Substances 0.000 description 7
- 230000014509 gene expression Effects 0.000 description 7
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 6
- 241001116500 Taxus Species 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 238000010276 construction Methods 0.000 description 6
- BHZOKUMUHVTPBX-UHFFFAOYSA-M sodium acetic acid acetate Chemical compound [Na+].CC(O)=O.CC([O-])=O BHZOKUMUHVTPBX-UHFFFAOYSA-M 0.000 description 6
- 241001149649 Taxus wallichiana var. chinensis Species 0.000 description 5
- 238000006555 catalytic reaction Methods 0.000 description 5
- 239000002299 complementary DNA Substances 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- 238000012408 PCR amplification Methods 0.000 description 4
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 4
- 230000006698 induction Effects 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 108030002602 10-deacetylbaccatin III 10-O-acetyltransferases Proteins 0.000 description 3
- 238000001042 affinity chromatography Methods 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000001976 enzyme digestion Methods 0.000 description 3
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 3
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229910052759 nickel Inorganic materials 0.000 description 3
- 238000005580 one pot reaction Methods 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 125000003241 10-deacetylbaccatin III group Chemical group 0.000 description 2
- 102000014914 Carrier Proteins Human genes 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 102000018120 Recombinases Human genes 0.000 description 2
- 108010091086 Recombinases Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241001052560 Thallis Species 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 108091008324 binding proteins Proteins 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 239000005515 coenzyme Substances 0.000 description 2
- 239000000287 crude extract Substances 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 230000009871 nonspecific binding Effects 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 238000002864 sequence alignment Methods 0.000 description 2
- 239000007974 sodium acetate buffer Substances 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 101001074429 Bacillus subtilis (strain 168) Polyketide biosynthesis acyltransferase homolog PksD Proteins 0.000 description 1
- 101000936617 Bacillus velezensis (strain DSM 23117 / BGSC 10A6 / FZB42) Polyketide biosynthesis acyltransferase homolog BaeD Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 235000001715 Lentinula edodes Nutrition 0.000 description 1
- 101710135898 Myc proto-oncogene protein Proteins 0.000 description 1
- 102100038895 Myc proto-oncogene protein Human genes 0.000 description 1
- 241000015728 Taxus canadensis Species 0.000 description 1
- 241000013871 Taxus globosa Species 0.000 description 1
- 241001674343 Taxus x media Species 0.000 description 1
- 101710150448 Transcriptional regulator Myc Proteins 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 101710159648 Uncharacterized protein Proteins 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 230000009435 amidation Effects 0.000 description 1
- 238000007112 amidation reaction Methods 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000006701 autoxidation reaction Methods 0.000 description 1
- 125000003834 baccatin III group Chemical group 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 230000008238 biochemical pathway Effects 0.000 description 1
- 238000003766 bioinformatics method Methods 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 230000006287 biotinylation Effects 0.000 description 1
- 238000007413 biotinylation Methods 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 1
- 239000005516 coenzyme A Substances 0.000 description 1
- 229940093530 coenzyme a Drugs 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000012468 concentrated sample Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000012084 conversion product Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 108010048367 enhanced green fluorescent protein Proteins 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 239000006167 equilibration buffer Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 229960001330 hydroxycarbamide Drugs 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000009465 prokaryotic expression Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000020175 protein destabilization Effects 0.000 description 1
- 238000002708 random mutagenesis Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 102200102592 rs104893740 Human genes 0.000 description 1
- 102200006532 rs112445441 Human genes 0.000 description 1
- 102220014333 rs112445441 Human genes 0.000 description 1
- 102220197780 rs121434596 Human genes 0.000 description 1
- 102220083576 rs143494325 Human genes 0.000 description 1
- 102220083998 rs551990619 Human genes 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000012807 shake-flask culturing Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000012916 structural analysis Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000004114 suspension culture Methods 0.000 description 1
- KFFHSFCOKCGBBW-VCPDXWRASA-N taxa-4(20),11-diene-2alpha,5alpha,10beta,14beta-tetrayl tetraacetate Chemical compound CC(=O)O[C@H]1C[C@]2(C)CC[C@H](OC(C)=O)C(=C)[C@H]2[C@H](OC(C)=O)[C@@H]2[C@@H](OC(=O)C)CC(C)=C1C2(C)C KFFHSFCOKCGBBW-VCPDXWRASA-N 0.000 description 1
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 description 1
- 125000002456 taxol group Chemical group 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y203/00—Acyltransferases (2.3)
- C12Y203/01—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
- C12Y203/01167—10-Deacetylbaccatin III 10-O-acetyltransferase (2.3.1.167)
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Description
Claims (10)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110477408.8A CN113980925B (zh) | 2016-05-24 | 2016-05-24 | 利用10-去乙酰巴卡亭III 10β-O-乙酰转移酶突变体催化合成紫杉醇及其衍生物 |
CN201610346558.4A CN107418938B (zh) | 2016-05-24 | 2016-05-24 | 10-去乙酰巴卡亭III 10β-O-乙酰转移酶突变体及其在催化合成紫杉醇及其类似物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610346558.4A CN107418938B (zh) | 2016-05-24 | 2016-05-24 | 10-去乙酰巴卡亭III 10β-O-乙酰转移酶突变体及其在催化合成紫杉醇及其类似物中的应用 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110477408.8A Division CN113980925B (zh) | 2016-05-24 | 2016-05-24 | 利用10-去乙酰巴卡亭III 10β-O-乙酰转移酶突变体催化合成紫杉醇及其衍生物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107418938A CN107418938A (zh) | 2017-12-01 |
CN107418938B true CN107418938B (zh) | 2022-07-15 |
Family
ID=60422498
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110477408.8A Active CN113980925B (zh) | 2016-05-24 | 2016-05-24 | 利用10-去乙酰巴卡亭III 10β-O-乙酰转移酶突变体催化合成紫杉醇及其衍生物 |
CN201610346558.4A Active CN107418938B (zh) | 2016-05-24 | 2016-05-24 | 10-去乙酰巴卡亭III 10β-O-乙酰转移酶突变体及其在催化合成紫杉醇及其类似物中的应用 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110477408.8A Active CN113980925B (zh) | 2016-05-24 | 2016-05-24 | 利用10-去乙酰巴卡亭III 10β-O-乙酰转移酶突变体催化合成紫杉醇及其衍生物 |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN113980925B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113980925B (zh) * | 2016-05-24 | 2024-05-14 | 中国医学科学院药物研究所 | 利用10-去乙酰巴卡亭III 10β-O-乙酰转移酶突变体催化合成紫杉醇及其衍生物 |
CN115247192A (zh) * | 2021-04-26 | 2022-10-28 | 中国医学科学院药物研究所 | 酰基/芳酰基辅酶a的酶法制备技术 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102159598A (zh) * | 2008-07-18 | 2011-08-17 | 巴斯夫欧洲公司 | 酶催化的聚丙烯酸酯水解方法和用于此的酯酶 |
CN102533705A (zh) * | 2012-02-24 | 2012-07-04 | 华东理工大学 | 一种腈水解酶及其基因和应用 |
CN104212821A (zh) * | 2014-07-25 | 2014-12-17 | 重庆医科大学 | Bcr-abl 融合蛋白突变体及其编码基因、表达载体及其构建方法和应用 |
CN105339490A (zh) * | 2012-12-20 | 2016-02-17 | 帝斯曼知识产权资产管理有限公司 | 乙酰转移酶及其用于产生类胡萝卜素的用途 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040005562A9 (en) * | 1999-09-30 | 2004-01-08 | Washington State University Research Foundation | Transacylases of the paclitaxel biosynthetic pathway |
CN106085987B (zh) * | 2015-05-25 | 2020-03-31 | 中国医学科学院药物研究所 | 具有β-木糖苷酶和β-葡萄糖苷酶双重活性的糖基水解酶突变体及其应用 |
CN105524893B (zh) * | 2016-01-15 | 2019-01-08 | 华南农业大学 | 一种dbat突变酶d166h及其应用 |
CN113980925B (zh) * | 2016-05-24 | 2024-05-14 | 中国医学科学院药物研究所 | 利用10-去乙酰巴卡亭III 10β-O-乙酰转移酶突变体催化合成紫杉醇及其衍生物 |
CN115125222A (zh) * | 2021-03-24 | 2022-09-30 | 中国医学科学院药物研究所 | 利用10-去乙酰巴卡亭III10β-O-乙酰转移酶突变体催化合成紫杉醇及其类似物 |
-
2016
- 2016-05-24 CN CN202110477408.8A patent/CN113980925B/zh active Active
- 2016-05-24 CN CN201610346558.4A patent/CN107418938B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102159598A (zh) * | 2008-07-18 | 2011-08-17 | 巴斯夫欧洲公司 | 酶催化的聚丙烯酸酯水解方法和用于此的酯酶 |
CN102533705A (zh) * | 2012-02-24 | 2012-07-04 | 华东理工大学 | 一种腈水解酶及其基因和应用 |
CN105339490A (zh) * | 2012-12-20 | 2016-02-17 | 帝斯曼知识产权资产管理有限公司 | 乙酰转移酶及其用于产生类胡萝卜素的用途 |
CN104212821A (zh) * | 2014-07-25 | 2014-12-17 | 重庆医科大学 | Bcr-abl 融合蛋白突变体及其编码基因、表达载体及其构建方法和应用 |
Non-Patent Citations (1)
Title |
---|
定点突变技术的研究进展;张浩;《免疫学杂志》;20000731;第16卷(第4期);全文 * |
Also Published As
Publication number | Publication date |
---|---|
CN107418938A (zh) | 2017-12-01 |
CN113980925A (zh) | 2022-01-28 |
CN113980925B (zh) | 2024-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106755209A (zh) | 一种酶法制备β‑烟酰胺单核苷酸的方法 | |
CN108823179A (zh) | 一种源自放线菌的转氨酶、突变体、重组菌及应用 | |
CN106754447B (zh) | 重组酿酒酵母及其在合成丙谷二肽中的应用 | |
CN108103039B (zh) | 一组岩藻糖基转移酶突变体及其筛选方法和应用 | |
CN107418938B (zh) | 10-去乙酰巴卡亭III 10β-O-乙酰转移酶突变体及其在催化合成紫杉醇及其类似物中的应用 | |
CN113736763B (zh) | 黑芥子酶Rmyr及其在制备萝卜硫素、莱菔素中的应用 | |
CN114196646B (zh) | 一种橄榄醇合成酶变体a及其用途 | |
Johansson et al. | Comparative sequence analysis and mutagenesis of ethylene forming enzyme (EFE) 2-oxoglutarate/Fe (II)-dependent dioxygenase homologs | |
CN112522228B (zh) | 一种来源于氨氧化假诺卡氏单胞菌的r-转氨酶及其合成方法 | |
CN115125222A (zh) | 利用10-去乙酰巴卡亭III10β-O-乙酰转移酶突变体催化合成紫杉醇及其类似物 | |
US20230220369A1 (en) | Taxadiene synthase tcts2, encoding nucleotide sequence and use thereof | |
CN108034646B (zh) | 一种催化活性和对映归一性提高的PvEH3突变体 | |
CN109355271A (zh) | 一种海洋红酵母来源的环氧化物水解酶及其应用 | |
CN112831532B (zh) | 一种酶促合成d-亮氨酸的方法 | |
CN106893748B (zh) | 一种l-茶氨酸的合成方法 | |
CN114657160B (zh) | 一种糖基转移酶突变体及其应用 | |
CN114703158A (zh) | 一种蔗糖磷酸化酶突变体、编码基因及其应用 | |
CN113621629A (zh) | 一种基于丙二酰辅酶a再生的柚皮素体外酶促合成方法 | |
CN110699345A (zh) | 一种卤醇脱卤酶突变体及其应用 | |
CN114854807B (zh) | 一种生产海藻糖六磷酸的方法 | |
CN114317631B (zh) | 单胺氧化酶在制备托品酮中的应用 | |
US20030175913A1 (en) | Compositions and methods for altering biosynthesis of taxanes and taxane-related compounds | |
WO2022148377A1 (zh) | 异源合成黄酮类化合物的宿主细胞及其应用 | |
CN114717170B (zh) | 异源合成黄酮类化合物的宿主细胞及其应用 | |
CN109370997B (zh) | 一种苯丙氨酸氨基变位酶突变体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhu Ping Inventor after: Li Bingjuan Inventor after: Wang Hao Inventor after: Chen Tianjiao Inventor after: Chen Jingjing Inventor after: Gong Ting Inventor after: Yang Jinling Inventor before: Zhu Ping Inventor before: Li Bingjuan Inventor before: Wang Hao Inventor before: Chen Tianjiao Inventor before: Chen Jingjing Inventor before: Gong Ting Inventor before: Yang Jinling |
|
CB03 | Change of inventor or designer information | ||
GR01 | Patent grant | ||
GR01 | Patent grant |